These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21947386)

  • 41. A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis.
    Kip MM; Kusters R; IJzerman MJ; Steuten LM
    J Med Econ; 2015; 18(11):944-53. PubMed ID: 26105574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do we need new trials of procalcitonin-guided antibiotic therapy?
    Lisboa T; Salluh J; Povoa P
    Crit Care; 2018 Jan; 22(1):17. PubMed ID: 29373980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective.
    Schuetz P; Balk R; Briel M; Kutz A; Christ-Crain M; Stolz D; Bouadma L; Wolff M; Kristoffersen KB; Wei L; Burkhardt O; Welte T; Schroeder S; Nobre V; Tamm M; Bhatnagar N; Bucher HC; Luyt CE; Chastre J; Tubach F; Mueller B; Lacey MJ; Ohsfeldt RL; Scheibling CM; Schneider JE
    Clin Chem Lab Med; 2015 Mar; 53(4):583-92. PubMed ID: 25581762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting.
    Deliberato RO; Marra AR; Sanches PR; Martino MD; Ferreira CE; Pasternak J; Paes AT; Pinto LM; dos Santos OF; Edmond MB
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):266-71. PubMed ID: 23711530
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients].
    Pundiche M; Sârbu V; Unc OD; Grasa C; Martinescu A; Bădărău V; Durbală I; Sapte E; Pasăre R; Voineagu L; Iordache I; Vâncă A; Adam A
    Chirurgia (Bucur); 2012; 107(1):71-8. PubMed ID: 22480120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotic consumption after implementation of a procalcitonin-guided antimicrobial stewardship programme in surgical patients admitted to an intensive care unit: a retrospective before-and-after analysis.
    Hohn A; Heising B; Hertel S; Baumgarten G; Hochreiter M; Schroeder S
    Infection; 2015 Aug; 43(4):405-12. PubMed ID: 25588968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials.
    Kopterides P; Siempos II; Tsangaris I; Tsantes A; Armaganidis A
    Crit Care Med; 2010 Nov; 38(11):2229-41. PubMed ID: 20729729
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can procalcitonin levels guide antibiotic therapy in bacterial infections and reduce antibiotic overconsumption without having a negative effect on clinical outcomes?
    Sandifer JP; Jones AE
    Ann Emerg Med; 2012 Sep; 60(3):370-1. PubMed ID: 22305332
    [No Abstract]   [Full Text] [Related]  

  • 50. Procalcitonin for guidance of antibiotic therapy.
    Schuetz P; Albrich W; Christ-Crain M; Chastre J; Mueller B
    Expert Rev Anti Infect Ther; 2010 May; 8(5):575-87. PubMed ID: 20455686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Procalcitonin-guided antibiotic use in acute respiratory tract infections.
    Bollu M; Marte-Grau AC; Bobba RK
    Arch Intern Med; 2009 Apr; 169(7):716. PubMed ID: 19365003
    [No Abstract]   [Full Text] [Related]  

  • 52. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study.
    Schroeder S; Hochreiter M; Koehler T; Schweiger AM; Bein B; Keck FS; von Spiegel T
    Langenbecks Arch Surg; 2009 Mar; 394(2):221-6. PubMed ID: 19034493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review.
    Agarwal R; Schwartz DN
    Clin Infect Dis; 2011 Aug; 53(4):379-87. PubMed ID: 21810753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis: A multicenter retrospective study.
    Maseda E; Suarez-de-la-Rica A; Anillo V; Tamayo E; García-Bernedo CA; Ramasco F; Villagran MJ; Maggi G; Gimenez MJ; Aguilar L; Granizo JJ; Buño A; Gilsanz F
    J Crit Care; 2015 Jun; 30(3):537-42. PubMed ID: 25600574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial.
    Schuetz P; Kutz A; Grolimund E; Haubitz S; Demann D; Vögeli A; Hitz F; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Marlowe RJ; Zimmerli W; Mueller B;
    Int J Cardiol; 2014 Aug; 175(3):464-72. PubMed ID: 25005339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Procalcitonin-guided antibiotic treatment in heart failure.
    Sandek A; Springer J; Habedank D; Brunkhorst F; Anker SD
    Lancet; 2004 May; 363(9420):1555; author reply 1555-6. PubMed ID: 15135615
    [No Abstract]   [Full Text] [Related]  

  • 57. Management of patients with respiratory infections in primary care: procalcitonin, C-reactive protein or both?
    Meili M; Müller B; Kulkarni P; Schütz P
    Expert Rev Respir Med; 2015 Oct; 9(5):587-601. PubMed ID: 26366806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
    Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
    Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL).
    Albrich WC; Dusemund F; Bucher B; Meyer S; Thomann R; Kühn F; Bassetti S; Sprenger M; Bachli E; Sigrist T; Schwietert M; Amin D; Hausfater P; Carre E; Gaillat J; Schuetz P; Regez K; Bossart R; Schild U; Mueller B;
    Arch Intern Med; 2012 May; 172(9):715-22. PubMed ID: 22782201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial.
    Hochreiter M; Köhler T; Schweiger AM; Keck FS; Bein B; von Spiegel T; Schroeder S
    Crit Care; 2009; 13(3):R83. PubMed ID: 19493352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.